does midi prescribe glp 1 The FDA has approved oral Wegovy—a daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP-1s., As Midi’s Chief Medical Officer, Dr. Kathleen Jordan Jenn W 2

Their perspectives illustrate how GLP-1 medications are raising new questions about cost, utilization, and long-term risk for insurers and policymakers

The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE-/- and LDLr-/- mice by a mechanism that includes inflammatory pathways

Mounjaro activates GIP and GLP-1 pathways to help control blood sugar in people with type 2 diabetes and helps with losing weight

Because of this risk, people with a personal or family history of medullary thyroid carcinoma (MTC) or those who have Multiple Endocrine Neoplasia syndrome Type 2 (MEN 2) should not use these GLP-1 medications

These findings help address ongoing safety concerns surrounding this widely prescribed class of medications